Valneva SE (VALN) Operating Leases (2020 - 2026)
Valneva SE's (VALN) quarterly Operating Leases came in at $28.6 million in Q1 2026, little changed year-on-year from $28.7 million in Q1 2025, and down 3.04% quarter-over-quarter from $29.5 million in Q4 2025.
Valneva SE (VALN) Operating Leases (2020 - 2026) Analysis & Trends
Valneva SE has disclosed Operating Leases across 7 years of filings, most recently posting $28.6 million for Q1 2026.
- Operating Leases for Q1 2026 came in at $28.6 million, changed 0.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.6 million (changed 0.27% YoY), and the FY2025 annual result was $29.5 million, down 4.61% from the prior year.
- Operating Leases came in at $28.6 million for Q1 2026 at Valneva SE, down from $29.5 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $59.1 million in Q1 2022 to a low of $28.6 million in Q2 2024.
- The 5-year median for Operating Leases is $30.3 million (2023), against an average of $36.1 million.
- Across the five-year window, Operating Leases tumbled 46.33% in 2023 and rose 4.13% in 2025, its largest moves.
- Valneva SE's Operating Leases stood at $54.7 million in 2022, then sank by 37.07% to $34.4 million in 2023, then decreased by 10.09% to $30.9 million in 2024, then declined by 4.61% to $29.5 million in 2025, then fell by 3.04% to $28.6 million in 2026.
- The last three Operating Leases figures came in at $28.6 million (Q1 2026), $29.5 million (Q4 2025), and $29.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.60 Mn |
| Dec 31, 2025 | 29.50 Mn |
| Sep 30, 2025 | 29.75 Mn |
| Jun 30, 2025 | 29.31 Mn |
| Mar 31, 2025 | 28.68 Mn |
| Dec 31, 2024 | 30.93 Mn |
| Sep 30, 2024 | 28.57 Mn |
| Jun 30, 2024 | 28.57 Mn |
| Mar 31, 2024 | 29.93 Mn |
| Dec 31, 2023 | 34.40 Mn |
| Sep 30, 2023 | 30.32 Mn |
| Jun 30, 2023 | 30.36 Mn |
| Mar 31, 2023 | 31.72 Mn |
| Dec 31, 2022 | 54.66 Mn |
| Sep 30, 2022 | 53.08 Mn |
| Jun 30, 2022 | 55.41 Mn |
| Mar 31, 2022 | 59.11 Mn |
| Dec 31, 2021 | 65.00 Mn |
| Dec 31, 2020 | 62.10 Mn |